Plants
Plants
Plants
Article
Antioxidant, Antigenotoxic and Cytotoxic Activity of Essential
Oils and Methanol Extracts of Hyssopus officinalis L. Subsp.
aristatus (Godr.) Nyman (Lamiaceae)
Tijana Mićović 1 , Dijana Topalović 2 , Lada Živković 2 , Biljana Spremo-Potparević 2 , Vladimir Jakovljević 3,4 ,
Sanja Matić 5 , Suzana Popović 6 , Dejan Baskić 6,7 , Danijela Stešević 8 , Stevan Samardžić 9 , Danilo Stojanović 10
and Zoran Maksimović 9, *
1 Institute for Medicines and Medical Devices of Montenegro, Bulevar Ivana Crnojevića 64a,
81000 Podgorica, Montenegro; tijana.micovic@calims.me
2 Department of Pathobiology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450,
11000 Belgrade, Serbia; dijana.topalovic@pharmacy.bg.ac.rs (D.T.); lada.zivkovic@pharmacy.bg.ac.rs (L.Ž.);
biljana.potparevic@pharmacy.bg.ac.rs (B.S.-P.)
3 Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69,
34000 Kragujevac, Serbia; drvladakgbg@yahoo.com
4 Department of Human Pathology, First Moscow State Medical University I. M. Sechenov, Trubetskaya Street
8, Str. 2, 119991 Moscow, Russia
5 Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69,
34000 Kragujevac, Serbia; sanjad.matic@gmail.com
6
Department of Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research,
Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia;
Citation: Mićović, T.; Topalović, D.; popovic007@yahoo.com (S.P.); dejan.baskic@gmail.com (D.B.)
Živković, L.; Spremo-Potparević, B.; 7 Public Health Institute, Nikole Pašića 1, 34000 Kragujevac, Serbia
Jakovljević, V.; Matić, S.; Popović, S.; 8 Faculty of Natural Sciences and Mathematics, University of Montenegro, Džordža Vašingtona bb,
Baskić, D.; Stešević, D.; Samardžić, S.; 81000 Podgorica, Montenegro; danijela.stesevic@ucg.ac.me
9 Department of Pharmacognosy, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450,
et al. Antioxidant, Antigenotoxic and
Cytotoxic Activity of Essential Oils 11000 Belgrade, Serbia; stevan.samardzic@pharmacy.bg.ac.rs
10 Department of Botany, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450,
and Methanol Extracts of Hyssopus
11000 Belgrade, Serbia; dancho@pharmacy.bg.ac.rs
officinalis L. Subsp. aristatus (Godr.)
* Correspondence: zmaksim1@pharmacy.bg.ac.rs
Nyman (Lamiaceae). Plants 2021, 10,
711. https://doi.org/10.3390/
Abstract: Hyssopus officinalis L. is a well-known aromatic plant used in traditional medicine and the food
plants10040711
and cosmetics industry. The aim of this study is to assess the antioxidant, genotoxic, antigenotoxic and
cytotoxic properties of characterized hyssop essential oils and methanol extracts. Chemical composition
Academic Editor: Suresh Awale
was analyzed by gas chromatography - mass spectrometry (GC-MS) and liquid chromatography with diode
Received: 25 February 2021
array detection and mass spectrometry (LC-DAD-MS), respectively. Antioxidant activity was examined
Accepted: 30 March 2021 by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric reducing/antioxidant power (FRAP) tests; genotoxic
Published: 7 April 2021 and antigenotoxic activity were examined by the comet assay, while cytotoxicity was evaluated by the 3-
(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide dye (MTT) test against tumor cell lines (SW480,
Publisher’s Note: MDPI stays neutral MDA-MB 231, HeLa) and non-transformed human lung fibroblast cell lines (MRC-5). The essential oils
with regard to jurisdictional claims in were rich in monoterpene hydrocarbons (e.g., limonene; 7.99–23.81%), oxygenated monoterpenes (1,8-
published maps and institutional affil- cineole; 38.19–67.1%) and phenylpropanoids (methyl eugenol; 0.00–28.33%). In methanol extracts, the most
iations. abundant phenolics were chlorogenic and rosmarinic acid (23.35–33.46 and 3.53–17.98 mg/g, respectively).
Methanol extracts expressed moderate to weak antioxidant activity (DPPH IC50 = 56.04–199.89 µg/mL,
FRAP = 0.667–0.959 mmol Fe2+/g). Hyssop preparations significantly reduced DNA damage in human
whole blood cells, induced by pretreatment with hydrogen peroxide. Methanol extracts exhibited selective
Copyright: © 2021 by the authors. and potent dose- and time-dependent activity against the HeLa cell line. Results of the current study
Licensee MDPI, Basel, Switzerland. demonstrated notable H. officinalis medicinal potential, which calls for further investigation.
This article is an open access article
distributed under the terms and Keywords: Hyssopus officinalis; antioxidant activity; antigenotoxic activity; comet assay; cytotoxic
conditions of the Creative Commons
activity; HeLa cell line; essential oil; methanol extract; GC-MS; LC-DAD-MS
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1. Introduction
Hyssop, Hyssopus officinalis L. (Lamiaceae), is a shrubby perennial herbaceous plant,
distributed mostly in the Mediterranean area [1–3]. In Montenegro and Serbia, Hyssopus
officinalis L. subsp. aristatus (Godr.) Nyman (syn. H. officinalis L. subsp. pilifer (Gris. ex
Pant.) Murb.) can be found in plant communities of rocky pastures [2].
Hyssop herb (Hyssopi herba) and its pharmaceutical preparations (infusions, syrups,
tinctures, extracts) have been used in traditional medicine since ancient times as antiseptic,
carminative, diaphoretic, emenagogue, expectorant, muscle relaxant, stomachic and tonic
agents. As an aromatic plant, it is also used in the food and cosmetics industry [4–6].
Essential oil is the most important and the most frequently investigated product of hyssop.
Available literature data on wild and cultivated plants indicate that its herb yields 0.3–1% of
essential oil with isopinocamphone as the dominant compound, along with pinocamphone,
β-pinene, 1,8-cineole, pinocarvone, linalool, sabinene and methyl eugenol [7–9]. Beside the
essential oil, hyssop herb contains flavonoids and phenolic acids, tannins, diterpene lactones
(marrubiin) and triterpenoid compounds such as ursolic and oleanolic acid [5,7,10].
Antimicrobial activity is one of the most commonly examined pharmacological effects of
various hyssop preparations. Extensive experimental evidence also speak in favor of antioxi-
dant [10], antiviral [11], sedative and anxiolytic [12,13], spasmolytic [14], anti-inflammatory [15],
antiulcer [16], anti-asthmatic [17] and antidiabetic activities of the hyssop herb [18]. However,
despite the diversity in scientific information on pharmacological activities of Hyssopi herba and
its preparations, genotoxicity, antigenotoxicity and cytotoxic activity of the essential oils and
polar extracts of this herbal drug are still insufficiently investigated.
In attempt to better understand medicinal potentials of H. officinalis herb in this field,
we designed and performed a set of chemical and physiological investigations on the
plant material collected from five wild-growing populations in Montenegro and on one
commercial sample available in herbal apothecaries in Serbia, and manufactured by a local
enterprise from wild-growing sources.
Hyssopi herba, as an herbal medicinal substance and a raw material for pharmaceutical
and related industries, is neither official in pharmacopoeias, nor listed in the other well-
established documents. Therefore, the question of its pharmaceutical quality still remains
open. Having in mind that growing (for plants harvested from the wild) and/or cultivation
conditions can significantly affect the composition and activity of a given plant, it would
explain the need for sampling at different sites, as well as the use of a commercial sample-
that is something that a person can find, if needed.
Consequently, the main objectives of the present work were to quantify the levels of
in vitro antioxidant activity by commonly used 2,2-diphenyl-1-picrylhydrazyl (DPPH) and
ferric reducing/antioxidant power (FRAP) tests, to assess potential genotoxicity/antigenoto
xicity by comet assay, and to determine the overall cytotoxic, cytostatic and cytocidal effects
against human tumor and non-transformed human lung fibroblast cell lines of investigated
hyssop essential oils and/or extracts, with respect to their chemical composition.
Table 1. Plant material: origin, collection data and yields of essential oils and extracts. a Values are the means of five consecutive determinations.
Table 2. Essential oil composition of Hyssopus officinalis subsp. aristatus. * Arithmetic retention index.
Amount (%)
tR [min] AI * Compound 1EO 2EO 3EO 4EO 5EO 6EO
5.517 925 α-Thujene 0.00 0.51 0.00 1.05 1.44 0.00
5.706 932 α-Pinene 2.08 4.13 1.12 0.53 0.79 1.03
6.762 972 Sabinene 1.86 1.24 0.57 0.47 0.54 0.56
6.872 976 β-Pinene 6.73 9.13 16.33 15.79 9.69 5.48
7.238 990 β-Myrcene 0.93 0.46 0.46 0.00 0.43 0.36
8.343 1024 p-Cymene 0.27 1.92 0.00 0.00 0.00 0.28
8.482 1028 Limonene 7.99 7.99 16.11 23.81 21.77 15.43
8.569 1030 1,8-Cineole 67.10 42.07 9.77 1.42 38.19 56.08
8.765 1036 Z-β-Ocimene 3.57 2.94 2.06 1.88 3.11 3.06
9.142 1046 E-β-Ocimene 0.27 0.00 0.00 0.00 0.00 0.00
9.531 1057 γ-Terpinene 0.31 0.58 0.00 0.00 0.00 0.00
12.592 1138 trans-Pinocarveol 0.23 2.26 0.83 0.54 0.00 0.61
13.463 1159 trans-Pinocamphone 0.00 1.84 3.34 8.34 4.72 0.00
13.556 1162 Pinocarvone 0.00 1.20 3.99 1.67 0.00 0.41
14.027 1173 cis-Pinocamphone 1.15 5.61 22.75 14.72 14.54 0.00
14.961 1196 Myrtenal 0.32 3.71 1.02 0.66 0.69 0.80
20.403 1325 Myrtenyl acetate 0.00 1.25 0.00 0.00 0.00 0.00
22.856 1384 β-Bourbonene 0.00 0.00 0.00 0.00 0.00 0.31
23.758 1406 Methyl eugenol 5.43 0.00 19.24 28.33 3.52 13.70
24.265 1418 E-β-Caryophyllene 0.47 0.00 0.00 0.00 0.00 0.00
26.771 1480 Germacrene D 0.40 0.00 0.00 0.00 0.00 0.36
Monoterpene hydrocarbons 24.01 28.9 36.65 43.53 37.77 26.2
Oxygenated monoterpenes 68.8 57.94 41.7 27.35 58.14 57.9
Sesquiterpene hydrocarbons 0.87 0.00 0.00 0.00 0.00 0.67
Phenylpropanoids 5.43 0.00 19.24 28.33 3.52 13.70
Total identified 99.11 86.84 97.59 99.21 99.43 98.47
Figure 1. Plots of principal component analysis (PCA) scores (a) and loadings (b) along the
two principal components (PCs) extracted from the dataset of Hyssopus officinalis essential
Figure 1. Plots of principal component analysis (PCA) scores (a) and loadings (b) along the first two principal components
from six mutually independent sources,
Figure 1. Plots as listed
of principal in Table
component 2. (PCA) scores (a) and loadings (b) a
analysis
(PCs) extracted from the dataset of Hyssopus officinalis essential oils from six mutually independent sources, as listed
two principal components (PCs) extracted from the dataset of Hyssopus officinalis es
in Table 2.
from six mutually independent sources, as listed in Table 2.
The cluster analysis of entire dataset revealed the similarity in the compos
Considering the previously reported literature data, numerous compounds have
essentialbeen
formerly oilsidentified
from the commercial
in essential
The ofsample
oilsanalysis
cluster hyssop of several
of and H.dataset
entire officinalis and the
chromatographic
revealed plants collected
profiles
similarity in the fc
locality
have beenCuce in Montenegro
described. essential oils(Cluster
from the 1), plants collected
commercial sample of H. from localities
officinalis Kuči coll
and plants an
Differences in oil composition
locality Cuce (deriving
in from
Montenegro climatic conditions,
(Cluster 1), plants the origin
collected
(Cluster 2) and plants collected from localities Šavnik and Piva (Cluster 3), as sh of plant
from localities K
material, subspecies or(Cluster
variety, developmental stages, soil type, cultivation technologies,
Figure 2. The results indicated that the classification proposed by the PCA and3
2) and plants collected from localities Šavnik and Piva (Cluster
extraction methods, etc.) determine
Figure its organoleptic
2. The results indicatedandthatphysiological properties,
the classification proposedandby the PC
chicalits
hence, cluster analysis
possibilities of (HCA)
application are in good
[1,5,7,19–23]. agreement.
chical cluster analysis (HCA) are in good agreement.
elemol, limonene, linalool, α-terpinene, myrtenol, myrtenyl acetate and methyl eugenol
were also reported [7].
With regard to the hyssop growing in Serbia, Mitić et al. (2000) identified cis-pinocamp-
hone (44.7%) as the most abundant constituent of its essential oil, followed by trans-
pinocamphone (14.1%), germacren-D-11-ol (5.7%) and elemol (5.6%) [19]. Gorunović et al.
(1995) examined hyssop from the territory of Montenegro. The main constituents were
methyl eugenol (38.30%), limonene (37.40%) and β-pinene (9.6%) [20].
Hajdari A. et al. (2018) investigated the composition of the essential oil of wild-
growing H. officinalis subsp. aristatus (aerial parts) from five different localities in Kosovo,
and found that in four out of five samples, the dominant compound was cis-pinocamphone,
with the content ranging between 30.44% and 57.73%. In a sample from one of the localities,
the dominant compound was 1,8-cineole (45.27%). The same authors found that the content
of trans-pinocamphone (14.76%) was significant in one of the samples, as well as that of
β-pinene (23.31%) and caryophyllene oxide (12.66%) [21].
The essential oils obtained from wild-growing H. officinalis L. subsp. aristatus in
Bulgaria in two stages of development (during the flower bud formation and in the full
bloom) were similar in composition, with 1,8-cineole (48.2% and 39.6%), isopinocamphone
(16.3% and 29.2%) and β-pinene (11.4% and 39.6%) as the major constituents. The essential
oil obtained from cultivated H. officinalis contained larger amounts of isopinocamphone
(40.2%), pinocamphone (10.3%) and β-pinene (14.2%), but no traces of 1,8-cineole [22].
In the essential oil of wild-growing H. officinalis subsp. aristatus (aerial parts) native to
Italy, the main compound was linalool (35.3–51.2%), whereas methyl eugenol (7.3–22.7%),
limonene (3.7–4.4%), germacrene D (1.9–4.1%), (Z)-β-ocimene (5.1–5.8%) and (E)-β-ocimene
(2.1–5.3%) were reported as well [5].
Our results revealed three chromatographic profiles in investigated essential oils of
wild-growing plants from Montenegro. The essential oil obtained from plants collected
from the locality Cuce in Montenegro (sample 6EO) was similar with the essential oil of the
commercial sample from southeastern Serbia (sample 1EO), being high in 1,8-cineole and
relatively rich in β-pinene, but low in cis-pinocamphone. On the other hand, the essential
oils of plants collected from the localities Šavnik and Piva in Montenegro (samples 3EO
and 4EO, respectively) stood out for being high in β-pinene, limonene, cis-pinocamphone
and methyl eugenol, but relatively low in 1,8-cineol at the same time. Finally, the essential
oils obtained from the plants collected from the localities Kuči and Piperi in Montenegro
(samples 2EO and 5EO, respectively) appeared to be relatively rich in 1,8-cineole, limonene,
β-pinene and cis-pinocamphone.
Table 3. Assignment, retention times, UV and MS spectral data of phenolic compounds in methanol extracts of Hyssopus
officinalis subsp. aristatus. a Identification by comparing with commercial reference compounds. b Tentative identification by
comparing acquired UV and MS spectral data with literature data.
Table 4. Content of total phenols, chlorogenic acid and rosmarinic acid in methanolic extracts of Hyssopus officinalis subsp.
aristatus. Different letters in the superscript indicate statistically different values at p < 0.05.
Sample Total Phenols (mg GAE/g) Chlorogenic Acid (mg/g) Rosmarinic Acid (mg/g)
c a
1E 74.7 ± 0.8 23.35 ± 0.2 13.71 ± 0.19 d
2E 68.2 ± 0.8 b 30.94 ± 0.11 d 5.35 ± 0.02 b
3E 64.1 ± 1.3 a 24.12 ± 0.11 b 3.53 ± 0.03 a
4E 112.0 ± 1.6 e 33.46 ± 0.08 e 17.98 ± 0.25 e
5E 81.8 ± 0.8 d 33.17 ± 0.1 e 4.97 ± 0.12 b
6E 69.0 ± 0.3 b 30.19 ± 0.1 c 8.13 ± 0.04 c
Identified phenolics were present in all extracts, regardless of the site of the plant
material collection. Variability was reflected through relatively small differences in the
concentrations of individual constituents. The content of chlorogenic acid was in the range
between 23.35 and 33.46 mg/g, whereas rosmarinic acid was present in lower amounts
(3.53–17.98 mg/g) (Table 4). Among the analyzed preparations, sample 4E was the richest
in chlorogenic and rosmarinic acids.
The results are in good agreement with the literature data. Previous studies of ethanol
and deodorized aqueous extracts of the aerial parts of wild-growing H. officinalis subsp.
aristatus (originating from central Italy and eastern Serbia) showed the presence of chloro-
genic acid, rosmarinic acid, 4-O-feruloylquinic acid and syringic acid [1,5]. Flavonoids,
isoquercitrin (quercetin 3-O-glucoside) and diosmin (diosmetin 7-O-rutinoside), were also
previously detected in extracts of hyssop herb [10,24]. In a study conducted by Borrelli
et al. (2019), ethanol macerate of the hyssop aerial parts was chemically analyzed and
the occurrence of caffeoyl pentoside, a hydroxycinnamate derivative, was confirmed [25].
In addition, a phenylethanoid glycoside martynoside was reported as a constituent of H.
seravshanicus [26]. The findings of other authors regarding the quantitative composition
of different extracts of hyssop herb are consistent with the presented results. Namely,
Venditti et al. (2015), as well as Hatipoğlu et al. (2013), demonstrated that the content of
chlorogenic acid is the highest among the quantities of phenolics [5,27]. Detailed analysis
indicated that the contents of chlorogenic acid in the examined samples were 4–5 times
higher than the corresponding values formerly reported, whereas the rosmarinic acid
contents were closer to the literature values. However, certain variations can be expected
and explained by a number of factors, e.g., differences in the extraction solvent used, the
extraction methodology, the origin of the plant material and/or the developmental stage of
the plant during collection.
The contents of total polyphenols (TPC) in tested samples ranged between 64.1 and
112.0 mg GAE/g (Table 4). The highest TPC was determined in sample 4E (112 mg GAE/g),
Plants 2021, 10, 711 8 of 21
whereas the lowest one was obtained in sample 3E (64.1 mg GAE/g). The sample richest
in chlorogenic and rosmarinic acids was also the richest in total polyphenols. The order of
the remaining extracts, by the decreasing TPCs, was: 5E > 1E > 6E > 2E.
Previous studies have yielded variable results, which is expected given that TPC can
be affected by numerous factors. Namely, reported values for TPC in several different
preparations of H. officinalis aerial parts were in a wide range, between 2.69 and 497.6 mg
GAE/g [1,10,21,25,28].
The lowest IC50 value, i.e., the best ability to neutralize DPPH radicals, was shown for
the extract 4E (56.04 µg/mL), followed by 5E (79.37 µg/mL), whereas the lowest activity
was observed in the case of 3E (199.89 µg/mL).
These results correlate well with the values of total antioxidant activity estimated
by the FRAP assay. Namely, the highest FRAP value was obtained for the 4E extract
(0.959 mmol Fe2+ /g), followed by the 5E extract (0.877 mmol Fe2+ /g), whereas the lowest
value was demonstrated for the 3E extract (0.667 mmol Fe2+ /g).
The data obtained in antioxidant assays correlate well with the contents of total
polyphenols, which are known as constituents that contribute to the antioxidant activity of
the plants. With regard to extracts 1E, 2E and 6E, there was no such strong link between
the antioxidant activity and total polyphenol contents as there was with the aforemen-
tioned extracts. Compared to standard substances (rutin and ascorbic acid), tested hyssop
preparations were less effective in DPPH radical scavenging and in the reduction of ferrous
ion-2,4,6-tri(2-pyridyl)-s-triazine complex (Table 5).
Taking into account the presented results, it can be concluded that moderate antioxi-
dant efficacy (IC50 < 100 µg/mL) was demonstrated for four of the six analyzed samples,
with the best activity shown for sample 4E.
Literature reports on hyssop aerial parts preparations indicate considerable variability
in IC50 values (25–2970 µg/mL) obtained in the DPPH test [1,10,25,28], which could be
expected as the geographical origin of plant material, extraction procedures and antioxidant
activity test protocols differ. With regard to the total antioxidant activity, Stanković et al.
(2016) examined methanol extract of vegetative parts of H. officinalis from southeastern
Serbia and found its FRAP value to be 0.73 mmol Fe2+ /g [29]. The current study FRAP
value is in good agreement with this reported value, as it ranged from 0.667 mmol Fe2+ /g
to 0.959 mmol Fe2+ /g. The chemical composition may help explain the documented
antioxidant activity. Namely, earlier published papers provide evidence that the dominant
compounds of the tested extracts (chlorogenic and rosmarinic acids) exhibit significant
efficacy in neutralizing DPPH radicals and reducing the ferrous ion complex [30–34].
ern Serbia and found its FRAP value to be 0.73 mmol Fe2+/g [29]. The current study FRAP
value is in good agreement with this reported value, as it ranged from 0.667 mmol Fe2+/g
to 0.959 mmol Fe2+/g. The chemical composition may help explain the documented anti-
oxidant activity. Namely, earlier published papers provide evidence that the dominant
Plants 2021, 10, 711 compounds of the tested extracts (chlorogenic and rosmarinic acids) exhibit significant
9 of 21
efficacy in neutralizing DPPH radicals and reducing the ferrous ion complex [30–34].
Figure 4. Antigenotoxic properties of essential oils of H. officinalis subsp. aristatus (1EO–6EO) against
Antigenotoxic
DNA4.damage
Figure in human properties of essential
peripheral oils of H. induced
blood leukocytes, officinalisby
subsp.
H2 O2aristatus (1EO–6EO)protocol.
in post-treatment
against DNA damage in human peripheral blood leukocytes, induced by
Bars represent the mean value of cells with DNA damage ± standard error of the meanH 2 O 2 in post-treatment
(SEM) versus
protocol. Bars represent the mean value of cells with DNA damage ± standard
control treated with H2 O2 (n = 3). PBS: phosphate-buffered saline solution. * p < 0.01, error of the**mean
p < 0.001,
(SEM) versus control
*** p < 0.0001. treated with H 2O2 (n = 3). PBS: phosphate-buffered saline solution. * p < 0.01,
Table 6. Concentrations of extracts (µg/mL) that induce inhibition of biological activity in 50% cells (IC50 ), 50% growth
inhibition (GI50 ), total growth inhibition (TGI) and 50% lethality (LC50 ) in the HeLa cell line, expressed as X ± SD. SI:
selectivity index.
HeLa 1E 2E 3E 4E 5E 6E
24 h >100 >100 >100 >100 >100 >100
IC50 48 h 22.72 ± 3.53 16.97 ± 2.10 44.38 ± 1.96 16.74 ± 1.43 25.90 ± 4.60 25.32 ± 7.80
72 h 19.53 ± 1.03 15.15 ± 1.72 33.43 ± 1.36 14.97 ± 0.78 18.73 ± 0.53 20.04 ± 5.10
24 h 0.97 1.52 1.71 1.31 1.10 3.61
SI 48 h 14.19 20.14 12.08 19.61 8.34 11.87
72 h 12.17 13.87 8.30 15.04 11.31 7.82
24 h 6.95 ±0.95 6.00 ± 0.34 98.09 ± 11.08 5.56 ± 0.18 7.67 ± 1.45 7.46 ± 0.99
GI50 48 h 4.91 ± 0.84 3.49 ± 0.46 65.64 ± 3.66 2.54 ± 0.45 5.61 ± 1.22 5.75 ± 0.68
72 h 0.86 ± 0.51 <0.3 59.38 ± 1.85 <0.3 4.97 ± 0.54 4.76 ± 0.52
24 h 16.90 ± 4.96 14.67 ± 0.58 >100 12.91 ± 0.44 47.25 ± 5.66 27.55 ± 1.89
TGI 48 h 13.60 ± 1.75 11.00 ± 0.56 >100 9.18 ± 0.59 19.90 ± 4.38 16.77 ± 1.52
72 h 13.27 ± 1.33 1.69 ± 0.36 >100 <0.3 18.42 ± 3.57 13.63 ± 1.26
24 h >100 >100 >100 >100 >100 >100
LC50 48 h 61.09 ± 16.15 35.65 ± 1.16 >100 27.07 ± 1.56 63.66 ± 2.30 41.15 ± 6.75
72 h 43.19 ± 10.03 26.02 ± 2.88 >100 20.28 ± 1.10 60.65 ± 1.59 31.20 ± 5.93
The data revealed that extracts 1E–6E displayed a statistically significant percentage
of growth inhibition in a dose-dependent manner on all designated cell lines after 48 h and
72 h (p < 0.05); however, that trend was not noticed after 24 h of treatment (p > 0.05). Time-
dependent growth inhibition was present only on the HeLa cell line with high statistical
significance (p < 0.0001), while a significant time-dependent effect was revealed only at
the highest examined concentration on MRC-5 and MDA-MB 231 cells (p < 0.05). On the
other hand, the increase in growth inhibition of the SW480 cell line was independent of the
exposure period.
To evaluate the overall inhibitory potential of the examined extracts, we calculated
IC50 as a parameter of growth inhibition in relation to the control, which did not take
into account the initial cell number at time zero. Examined extracts showed very low
overall inhibitory activity against healthy cell line MRC-5, but also against the SW480 and
MDA-MB 231 tumor cell lines, because their IC50 values exceeded the highest examined
concentration (data not shown). On the other hand, the HeLa cell line was susceptible
to their effect with high overall inhibition indicated by low IC50 values. Extracts 2E and
4E exhibited the strongest overall inhibitory activity after 48 h and 72 h of treatment,
followed by extracts 1E, 5E and 6E, while extract 3E had the highest IC50 . Regardless,
there was no statically significant difference among the tested extracts. Importantly, the
extracts displayed activity highly selective for HeLa cells with selectivity index (SI) values
that ranged between 8 and 20. Antitumor activity of most clinically applied agents is
restricted because of their large spectrum of side effects and general toxicity, including to
some normal cells. Although scientists continue to develop compounds with a targeted
mechanism of action, many of those compounds still lack selectivity for tumor cells [39]. In
that term, natural products are considered as less toxic for normal cells and as a biologically
friendly approach, as evidenced by the large number of extracts and secondary metabolites
in clinical trials [40].
Further, according to National Cancer Institute (NCI) recommendations [41], we
calculated three parameters to disclose whether the examined extracts had cytostatic
(GI50 , TGI) or cytocidal (LC50 ) effects on designated cell lines (Table 6). The calculated
parameters showed low to absent cytostatic or cytocidal activity of tested extracts 1E–
6E against the SW480 and MDA-MB 231 cancer cell lines and, importantly, against the
non-transformed cell line MRC-5 (data not shown). Contrarily, on the HeLa cell line,
all examined extracts acted as very potent inhibitors of net cell growth with very low
Plants 2021, 10, 711 12 of 21
GI50 values, especially extracts 2E and 4E, which exhibited a net cell growth inhibition
for 50% of cells at concentrations lower than the minimum concentration examined after
72 h of treatment (GI50 < 0.3 µg/mL). Extracts 1E, 5E and 6E exhibited a net cell growth
inhibition of 50%, with similar potency as the previous extracts. Compared to the extract of
commercial hyssop herb (1E), only extract 3E had lower cell growth inhibition activity with
a high statistical significance (p < 0.0001). The same trend was present in the perspective of
total growth inhibition and cytocidal activity. Namely, extracts 2E and 4E provoked strong
cytostatic effect after 72 h of treatment with TGI values of 1.69 µg/mL and <0.3 µg/mL,
respectively. Also, LC50 values of these extracts were significantly lower than for other
extracts (p < 0.05), indicating their potent cytocidal nature. Extracts 1E, 5E and 6E followed
the same trend. The tumor grows when the total rate of division of its cells exceeds the
total mortality rate. The ability to grow uncontrollably is gained through the accumulation
of mutations of genes that manage cell proliferation and cell death. Therefore, the agents
that can override these defects, stop uncontrolled cell division and kill cancer cells are
beneficial in cancer treatment. Tested extracts 1E, 2E and 4E–6E showed, along with high
selectivity, a potent ability both to inhibit cell proliferation and to induce cell death in a
human cervical cancer cell line. Therefore, those extracts and their compounds should be
further examined for their possible application in the therapy of this type of cancer.
The dominant compounds in the extracts are, as mentioned above, chlorogenic and
rosmarinic acids, whose cytotoxic potential has been reported earlier [42,43]. The extract
4E had the highest content of chlorogenic and rosmarinic acids, as well as total phenolic
compounds, while the extract 3E, which exhibited the weakest cytotoxic activity compared
to other tested extracts, had the lowest contents of total phenols and rosmarinic acid. On
the other hand, the extract 2E, which also gave very good results in this study, together with
the extract 4E, was distinguished neither by the content of total phenols nor by chlorogenic
or rosmarinic acids. The extracts 2E and 4E also showed antigenotoxic activity in the
comet assay (post-treatment protocol). Therefore, we can conclude that chlorogenic and
rosmarinic acid probably contributed to the overall cytotoxic potential of the methanol
extract of hyssop herb. The contribution of individual components of the extract and/or
their synergistic/additive action to selective cytotoxicity against HeLa cells is of particular
interest and should be further investigated in the future.
The methanol solutions of the tested hyssop extracts were prepared in different con-
centrations, along with the standard methanol solutions of rutin. The test solution consisted
of a mixture of 0.1 mL of the methanol solution of tested extract, 0.1 mL of methanol and
0.05 mL of 0.5 mM methanol solution of DPPH. The mixtures were shaken vigorously and
incubated for 30 min in the dark at room temperature. The absorbances were measured at
492 nm against methanol as a blank test on Biochrom EZ Read 400 microtiter plate reader.
The negative control consisted of 0.2 mL of methanol and 0.05 mL of 0.5 mmol/L DPPH
solution. DPPH inhibition was calculated according to the following formula:
where Ac is the absorbance of the control and At is the absorbance of test solutions.
The results are expressed as half-maximum inhibitory concentration (IC50 values;
µg/mL) values, which denote the concentrations that neutralize 50% of DPPH radicals and
are the mean values of the three consecutive determinations.
400 µg/mL was chosen for further testing, because it was the most effective concentration
in the antigenotoxic assessment of commercial extract. The attenuation of H2 O2 -induced
DNA damage in human peripheral blood leukocytes in the post-treatment with EO was
assessed using the concentration that did not induce a statistically significant increase of
DNA damage in the tested cells in the genotoxicity assessment (2.5 µg/mL).
(~80%) in the logarithmic growth phase were detached from the bottom of the flask by
short-term treatment with 0.25% trypsin and 0.53 mM EDTA combination dissolved in
phosphate-buffered saline.
the effect was not reached or was exceeded, the value for that parameter was expressed as
greater or less than the maximum or minimum concentration tested.
3.11. Statistics
The results of the experiments are represented as mean ± standard deviation.
Principal component analysis (PCA) and hierarchical cluster analysis (HCA) using
Statistica® v.8.0 (www.statsoft.com, accessed on 1 April 2021) and StatistiXL® Version
2.0 add-in for MS Excel® (www.statistixl.com, accessed on 1 April 2021) were applied to
examine the interrelationships between the chemical compositions of the essential oils.
The results of LC-MS quantitative analysis and assays on antioxidant activity were
analyzed by SPSS software (version 20.0) using one-way ANOVA and post hoc Tukey’s test.
Differences between the mean values were considered statistically significant if p < 0.05.
The IC50 , GI50 , TGI and LC50 parameters were calculated using MS Office Excel® free
add-in ED50 plus v1.0 software (www.sciencegateway.org/protocols/cellbio/drug/data/,
accessed on 1 April 2021). SPSS software version 20 was used for statistical data analysis.
The Shapiro–Wilk test was used to test the normality of data distribution. Depending
on the results normality test, for the comparison of groups, one-way analysis of variance
(ANOVA) or its non-parametric equivalent Kruskal–Wallis test was used.
For the genotoxic and antigenotoxic activity assays, the results are expressed as the
mean value (n = 3) ± standard error of the mean (SEM). Statistical analysis of the comet
assay results was performed using one-way analysis of variance (ANOVA) with Tukey’s
post hoc test for comparisons of different treatments vs. the respective controls. GraphPad
Prism 6.0 software was used. A regression was used to determine the effect of the bioactive
substance concentration on the outcome. The values of the obtained data were considered
statistically significant if p < 0.05, and statistically highly significant if p < 0.001.
4. Conclusions
This study evaluated the antioxidant activity and genotoxicity/antigenotoxicity, as
well as cytotoxic, cytostatic and cytocidal effects against human tumor and non-transformed
human lung fibroblast cell lines of the investigated Hyssopus officinalis essential oils and/or
extracts, with respect to their chemical composition. Our results revealed high variability
in the composition of essential oils, as three chromatographic profiles of the investigated
essential oils of wild-growing plants from Montenegro could be distinguished: oils rich
in 1,8-cineole and relatively rich in β-pinene, but low in cis-pinocamphone; oils rich in
β-pinene, limonene, cis-pinocamphone and methyl eugenol, but relatively low in 1,8-cineol;
and oils relatively rich in 1,8-cineole, limonene, β-pinene and cis-pinocamphone. The
essential oil from the commercial plant material from Serbia, being rich in 1,8-cineole
and β-pinene, but low in cis-pinocamphone, appeared similar to only one of the samples
obtained from wild-growing plants from Montenegro. Both the extracts and the essential
oils significantly reduced in vitro DNA damage. In addition, potent and selective cytotoxic
action of the hyssop methanol extracts on the HeLa cell line was observed. These findings
deserve closer attention and our further investigations, which will be performed in the
prospective future, and should be directed to the panel of cancer cell lines derived from the
most sensitive tissue (cervix), along with a detailed mechanism of antitumor effect and the
isolation/chemical characterization of the constituents that are presumably responsible for
observed activity.
Author Contributions: T.M. participated in all the experiments (as a part of her PhD work) and
wrote the manuscript draft. D.T. performed investigation on genotoxicity and antigenotoxicity, the vi-
sualization of the data and contributed to writing the original draft. L.Ž. performed investigation and
provided resources for the tests on genotoxicity and antigenotoxicity. B.S.-P. performed investigation,
provided methodology for the tests of genotoxicity and antigenotoxicity, and conducted supervi-
sion. V.J. provided resources, methodology and supervision for investigations on cytotoxic activity.
S.M., S.P. and D.B. performed investigations on cytotoxic activity, their validation, visualization and
writing of the original draft. D.S. (Danijela Stešević) and D.S. (Danilo Stojanović) performed field
investigations, identified plant material and performed the writing, review and editing process. S.S.
performed chromatographic analyses and the interpretation of collected data, and also contributed
to writing of the original draft and the review and editing processes. Z.M. was responsible for the
conceptualization, resources, supervision, and the writing, review and editing process. All authors
have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Institutional Review Board Statement: The study on genotoxic and antigenotoxic activity was
conducted according to the guidelines of the Declaration of Helsinki, and approved by Ethics
Committee for biomedical investigations at the Faculty of Pharmacy in Belgrade (protocol code
1121/2; date of approval: 31 August 2020).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the
study on genotoxic and antigenotoxic activity.
Data Availability Statement: Data available upon request.
Acknowledgments: Supported by the Ministry of Education, Science and Technological Develop-
ment of the Republic of Serbia; contract No. 451-03-9/2021-14/200161.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Džamić, A.; Soković, M.; Novaković, M.; Jadranin, M.; Ristić, M.; Tešević, V.; Marin, P. Composition, antifungal and antioxidant
properties of Hyssopus officinalis L. subsp. pilifer (Pant.) Murb. essential oil and deodorized extracts. Ind. Crop. Prod. 2013, 51,
401–407. [CrossRef]
2. Diklić, N. Hyssopus L. In Flora SR Srbije; Josifović, M., Ed.; SANU: Beograd, Serbia, 1974; pp. 472–474.
3. World Checklist of Selected Plant Families. Copyright The Board of Trustees of the Royal Botanic Gardens, Kew. 2010. Available
online: http://ww2.bgbm.org/EuroPlusMed/ (accessed on 12 March 2021).
4. Tucakov, J. Lečenje Biljem; Zapis: Beograd, Serbia, 2010.
5. Venditti, A.; Bianco, A.; Frezza, C.; Conti, F.; Bini, L.; Giuliani, C.; Bramucci, M.; Quassinti, L.; Damiano, S.; Lupidi, G.; et al.
Essential oil composition, polar compounds, glandular trichomes and biological activity of Hyssopus officinalis subsp. aristatus
(Godr.) Nyman from central Italy. Ind. Crop. Prod. 2015, 77, 353–363. [CrossRef]
6. Kišgeci, J. Lekovite i Aromatične Biljke; Partenon, Srpska Književna Zadruga: Novi Sad, Serbia, 2008.
7. Judžentienė, A. Hyssop (Hyssopus officinalis L.) Oil. In Essential Oils in Food Preservation, Flavor and Safety; Preedy, V., Ed.; Elsevier,
Academic Press: London, UK, 2016; pp. 471–479.
8. ISO 9841 Standard. ISO 9841:2013—Essential oil of hyssop (Hyssopus officinalis L. ssp. officinalis). Available online: https:
//www.iso.org/standard/57475.html (accessed on 19 May 2018).
9. Hristova, Y.R.; Wanner, J.; Jirovetz, L.; Stappen, I.; Iliev, I.A.; Gochev, V. Chemical composition and antifungal activity of essential
oil of Hyssopus officinalis L. from Bulgaria against clinical isolates of Candida species. Biotechnol. Biotechnol. Equip. 2015, 29, 592–601.
[CrossRef]
10. Vlase, L.; Benedec, D.; Hanganu, D.; Damian, G.; Csillag, I.; Sevastre, B.; Mot, A.; Silaghi-Dumitrescu, R.; T, ilea, I. Evaluation of
Antioxidant and Antimicrobial Activities and Phenolic Profile for Hyssopus officinalis, Ocimum basilicum and Teucrium chamaedrys.
Molecules 2014, 19, 5490–5507. [CrossRef]
11. Kreis, W.; Kaplan, M.; Freeman, J.; Sun, D.K.; Sarin, P. Inhibition of HIV replication by Hyssopus officinalis extracts. Antivir. Res.
1990, 14, 323–337. [CrossRef]
12. Lim, W.C.; Seo, J.; Lee, C.I.; Pyo, H.B.; Lee, B.C. Stimulative and sedative effects of essential oils upon inhalation in mice. Arch.
Pharmacal Res. 2005, 28, 770–774. [CrossRef] [PubMed]
13. Salehi, A.; Setorki, M. Effect of Hyssopus officinalis essential oil on chronic stress-induced memory and learning impairment in
male mice. Bangladesh J. Pharmacol. 2017, 12, 448–454. [CrossRef]
14. Lu, M.; Battinelli, L.; Daniele, C.; Melchioni, C.; Salvatore, G.; Mazzanti, G. Muscle relaxing activity of Hyssopus officinalis essential
oil on isolated intestinal preparations. Planta Med. 2002, 68, 213–216. [CrossRef]
15. Charles, D.J. Hyssop. In Antioxidant Properties of Spices, Herbs and Other Sources; Charles, D.J., Ed.; Springer: New York, NY, USA, 2013.
Plants 2021, 10, 711 20 of 21
16. Păun, G.; Litescu, S.C.; Neagu, E.; Tache, A.; Radu, G.L. Evaluation of Geranium spp., Helleborus spp. and Hyssopus spp.
polyphenolic extracts inhibitory activity against urease and α-chymotrypsin. J. Enzym. Inhib. Med. Chem. 2014, 29, 28–34.
[CrossRef]
17. Ma, X.; Ma, X.; Ma, Z.; Sun, Z.; Yu, W.; Wang, J.; Li, F.; Ding, J. The Effects of Uygur Herb Hyssopus officinalis L. on the Process of
Airway Remodeling in Asthmatic Mice. Evid. Based Complementary Altern. Med. 2014, 2014, 710870. [CrossRef]
18. Miyazaki, H.; Matsuura, H.; Yanagiya, C.; Mizutani, J.; Tsuji, M.; Ishihara, C. Inhibitory effects of hyssop (Hyssopus officinalis)
extracts on intestinal alpha-glucosidase activity and postprandial hyperglycemia. J. Nutr. Sci. Vitaminol. 2003, 49, 346–349.
[CrossRef] [PubMed]
19. Mitić, V.; Ðord̄ević, S. Essential oil composition of Hyssopus officinalis L. cultivated in Serbia. Facta Univ. Ser. Phys. Chem. Technol.
2000, 2, 105–108.
20. Gorunović, M.; Bogavac, P.M.; Chalchat, J.; Chabard, J.L. Essential Oil of Hyssopus officinalis L., Lamiaceae of Montenegro Origin.
J. Essent. Oil Res. 1995, 7, 39–43. [CrossRef]
21. Hajdari, A.; Giorgi, A.; Beretta, G.; Gelmini, F.; Buratti, S.; Benedetti, S.; Merkouri, A.; Mala, X.; Kabashi, S.; Pentimalli, D.; et al.
Phytochemical and sensorial characterization of Hyssopus officinalis subsp. aristatus (Godr.) Nyman (Lamiaceae) by GC–MS,
HPLC–UV–DAD, spectrophotometric assays and e-nose with aid of chemometric techniques. Eur. Food Res. Technol. 2018, 244,
1313–1327. [CrossRef]
22. Tsankova, E.; Konaktchiev, A.N.; Génova, E. Chemical composition of the essential oils of two Hyssopus officinalis taxa. J. Essent.
Oil Res. 1993, 5, 609–611. [CrossRef]
23. Moro, A.; Zalacain, A.; Mendoza, J.H.; Carmona, M. Effects of agronomic practices on volatile composition of Hyssopus officinalis
L. essential oils. Molecules 2011, 16, 4131–4139. [CrossRef]
24. Marín, F.R.; Ortuño, A.; Benavente-García, O.; Río, J.D. Distribution of flavone glycoside diosmin in Hyssopus officinalis plants:
Changes during growth. Planta Med. 1998, 64, 181–182. [CrossRef] [PubMed]
25. Borrelli, F.; Pagano, E.; Formisano, C.; Piccolella, S.; Fiorentino, A.; Tenore, G.C.; Izzo, A.; Rigano, D.; Pacifico, S. Hyssopus
officinalis subsp. aristatus: An unexploited wild-growing crop for new disclosed bioactives. Ind. Crop. Prod. 2019, 140, 111594.
[CrossRef]
26. Shomirzoeva, O.; Li, J.; Numonov, S.; Mamat, N.; Shataer, D.; Lu, X.; Aisa, H.A. Chemical components of Hyssopus seravshanicus:
Antioxidant activity, activations of melanogenesis and tyrosinase, and quantitative determination by UPLC-DAD. Nat. Prod. Res.
2019, 33, 866–870. [CrossRef]
27. Hatipoğlu, G.; Sökmen, M.; Bektaş, E.; Daferera, D.; Sökmen, A.; Demir, E.; Şahin, H. Automated and standard extraction of
antioxidant phenolic compounds of Hyssopus officinalis L. ssp. angustifolius. Ind. Crop. Prod. 2013, 43, 427–433. [CrossRef]
28. Fathiazad, F.; Mazandarani, M.; Hamedeyazdan, S. Phytochemical analysis and antioxidant activity of Hyssopus officinalis L. From
Iran. Adv. Pharm. Bull. 2011, 1, 63–67. [PubMed]
29. Stanković, N.; Mihajilov-Krstev, T.; Zlatković, B.; Stankov-Jovanović, V.; Mitić, V.; Jović, J.; Čomić, L.; Kocić, B.; Bernstein, N.
Antibacterial and antioxidant activity of traditional medicinal plants from the Balkan Peninsula. NJAS Wagening. J. Life Sci. 2016,
78, 21–28. [CrossRef]
30. Ohnishi, M.; Morishita, H.; Iwahashi, H.; Toda, S.; Shirataki, Y.; Kimura, M.; Kido, R. Inhibitory effects of chlorogenic acids on
linoleic acid peroxidation and haemolysis. Phytochemistry 1994, 36, 579–583. [CrossRef]
31. Biskup, I.; Golonka, I.; Gamian, A.; Sroka, Z. Antioxidant activity of selected phenols estimated by ABTS and FRAP methods.
Postepy Hig. Med. Dosw. 2013, 67, 958–963. [CrossRef]
32. Adomakobonsu, A.G.; Chan, S.L.; Pratten, M.; Fry, J.R. Antioxidant activity of rosmarinic acid and its principal metabolites
in chemical and cellular systems: Importance of physico-chemical characteristics. Toxicol. Vitr. 2017, 40, 248–255. [CrossRef]
[PubMed]
33. Adımcılar, V.; Kalaycıoğlu, Z.; Aydoğdu, N.; Dirmenci, T.; Kahraman, A.; Erim, F.B. Rosmarinic and carnosic acid contents and
correlated antioxidant and antidiabetic activities of 14 Salvia species from Anatolia. J. Pharm. Biomed. Anal. 2019, 175, 112763.
[CrossRef]
34. Benedec, D.; Hanganu, D.; Oniga, I.; Tiperciuc, B.; Olah, N.; Raita, O.; Bischin, C.; Silaghi-Dumitrescu, R.; Vlase, L. Assessment of
rosmarinic acid content in six Lamiaceae species extracts and their antioxidant and antimicrobial potential. Pak. J. Pharm. Sci.
2015, 28, 2297–2303.
35. Abraham, S.K.; Schupp, N.; Schmid, U.; Stopper, H. Antigenotoxic effects of the phytoestrogen pelargonidin chloride and the
polyphenol chlorogenic acid. Mol. Nutr. Food Res. 2007, 51, 880–887. [CrossRef]
36. De Oliveira, N.C.; Sarmento, M.S.; Nunes, E.A.; Porto, C.M.; Rosa, D.P.; Bona, S.R.; da Silva, J. Rosmarinic acid as a protective
agent against genotoxicity of ethanol in mice. Food Chem. Toxicol. 2012, 50, 1208–1214. [CrossRef]
37. Choi, Y.K.; Cho, G.; Hwang, S.; Kim, B.; Lim, J.H.; Lee, J.; Kim, H.; Kim, W.; Kim, Y. Methyleugenol reduces cerebral ischemic
injury by suppression of oxidative injury and inflammation. Free Radic. Res. 2010, 44, 925–935. [CrossRef]
38. Ciftci, O.; Ozdemir, I.; Tanyildizi, S.; Yıldız, S.; Oguzturk, H. Antioxidative effects of curcumin, β-myrcene and 1,8-cineole against
2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in rats liver. Toxicol. Ind. Health 2011, 27, 447–453. [CrossRef]
39. Chari, R.V. Targeted cancer therapy: Conferring specificity to cytotoxic drugs. Acc. Chem. Res. 2008, 41, 98–107. [CrossRef]
[PubMed]
Plants 2021, 10, 711 21 of 21
40. Seca, A.; Pinto, D. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.
Int. J. Mol. Sci. 2018, 19, 263. [CrossRef]
41. Boyd, M.R. The NCI Human Tumor Cell Line (60-Cell) Screen. In Anticancer Drug Development Guide. Cancer Drug Discovery and
Development; Teicher, B.A., Andrews, P.A., Eds.; Humana Press: Totowa, NJ, USA, 2004. [CrossRef]
42. Moon, A.; Agrawa, T.; Gupta, P.; Kondlekar, N.; Taksande, A. Anti-cancer therapy: Chlorogenic acid, gallic acid and ellagic acid
in synergism. IOSR J. Pharm. Biol. Sci. 2017, 12, 48–52. [CrossRef]
43. Hossan, M.S.; Rahman, S.; Bashar, A.B.M.A.; Rahmatullah, M. Rosmarinic acid: A review of its anticancer action. World J. Pharm.
Pharm. Sci. 2014, 3, 57–70.
44. DeFilipps, R.A. Hyssopus L. In Flora Europaea; Tutin, T.G., Heywood, V.H., Burges, N.A., Moore, D.M., Valentine, D.H., Walters,
S.M., Webb, D.A., Eds.; Cambridge University Press: Cambridge, UK, 1972; Volume 3, pp. 170–171.
45. Savezni Zavod za Zdravstvenu Zaštitu. Pharmacopoea Jugoslavica, 4th ed.; Savezni Zavod za Zdravstvenu Zaštitu: Beograd, Serbia, 1984.
46. McLafferty, F.W. The Wiley Registry of Mass Spectral Data, 7th ed.; John Wiley and Sons, Inc.: New York, NY, USA, 2000.
47. NIST Mass Spectrometry Data Center. NIST Mass Spectral Library ver. 05; NIST Mass Spectrometry Data Center: Gaithersburg,
MD, USA, 2005.
48. Adams, R. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry, 4th ed.; Allured Business Media:
Carol Stream, IL, USA, 2012.
49. International Conference on Harmonisation (ICH). ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and
Methodology Q2 (R1); ICH: Geneva, Switzerland, 2005.
50. Velioglu, Y.; Mazza, G.; Gao, L.; Oomah, B. Antioxidant Activity and Total Phenolics in Selected Fruits, Vegetables, and Grain
Products. J. Agric. Food Chem. 1998, 46, 4113–4117. [CrossRef]
51. Kukić, J.; Petrović, S.; Niketić, M. Antioxidant activity of four endemic Stachys taxa. Biol. Pharm. Bull. 2006, 29, 725–729. [CrossRef]
52. Pellegrini, N.; Serafini, M.; Colombi, B.; Del Rio, D.; Salvatore, S.; Bianchi, M.; Brighenti, F. Total Antioxidant Capacity of
Plant Foods, Beverages and Oils Consumed in Italy Assessed by Three Different In Vitro Assays. J. Nutr. 2003, 133, 2812–2819.
[CrossRef]
53. Shin, S.Y.; Kim, H.; Kang, S.W.; Cho, H.; Kim, E.J.; Park, S.H.; Park, K.M. Antioxidant and Anti-Melanogenic Activities of Hyssopus
officinalis Extracts. J. Soc. Cosmet. Sci. Korea 2016, 42, 195–201. [CrossRef]
54. Di Sotto, A.; Mazzanti, G.; Carbone, F.; Hrelia, P.; Maffei, F. Genotoxicity of lavender oil, linalyl acetate, and linalool on human
lymphocytes in vitro. Environ. Mol. Mutagen. 2011, 52, 69–71. [CrossRef]
55. Živković, L.; Čabarkapa, A.; Marčetić, M.; Kovačević, N.; Bajić, V.; Jovičić, S.; Spremo-Potparević, B. Evaluation of genotoxic and
antigenotoxic properties of essential oils of Seseli rigidum Waldst. & Kit. (Apiaceae). Arch. Biol. Sci. 2016, 68, 135–144.
56. Živković, L.; Bajić, V.; Dekanski, D.; Čabarkapa-Pirković, A.; Giampieri, F.; Gasparrini, M.; Mazzoni, L.; Potparević, B.S. Manuka
honey attenuates oxidative damage induced by H2 O2 in human whole blood in vitro. Food Chem. Toxicol. 2018, 119, 61–65.
[CrossRef] [PubMed]
57. Singh, N.P.; McCoy, M.T.; Tice, R.R.; Schneider, E.L. A simple technique for quantitation of low levels of DNA damage in
individual cells. Exp. Cell Res. 1988, 175, 184–191. [CrossRef]
58. Anderson, D.; Yu, T.-W.; Phillips, B.; Schmezer, P. The effect of various antioxidants and other modifying agents on oxygen-
radical-generated DNA damage in human lymphocytes in the COMET assay. Mutat. Res. Mol. Mech. Mutagen. 1994, 307, 261–271.
[CrossRef]
59. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J.
Immunol. Methods 1983, 65, 55–63. [CrossRef]
60. Koch, A.; Tamez, P.; Pezzuto, J.; Soejarto, D. Evaluation of plants used for antimalarial treatment by the Maasai of Kenya. J.
Ethnopharmacol. 2005, 101, 95–99. [CrossRef]